Liver Cirrhoses: Clinical Trials

2 trials for Liver Cirrhoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Liver Cirrhoses: new trials by email Literature Review of Liver Cirrhoses trials Research Report on Liver Cirrhoses

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
Placebo oral tablet, Atorvastatin 10mg - Liver Cirrhoses
Phase 4TerminatedCopenhagen University Hospital, Hvidovre782019-11-082023-01-13
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Octreotide - Esophageal Varices, Liver Cirrhoses
Phase 4TerminatedMedical University of South Carolina342018-09-192025-11-20

Narrower conditions

Esophageal and Gastric Varices (1)  ·  Gastrointestinal Hemorrhage (1)

Broader conditions

Digestive System Diseases (1)  ·  Esophageal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hemorrhage (1)  ·  Hypertension, Portal (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Atorvastatin (1)  ·  Octreotide (1)

Sponsors

Copenhagen University Hospital, Hvidovre (1)  ·  Medical University of South Carolina (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Don Rockey, M.D (1)  ·  Flemming Bendtsen, DmSci (1)  ·  Thit M Kronborg, MD (1)

Results publications

PMID 11864921, PMID 31980514, PMID 39241828